Generalized anxiety disorder: A review of recent findings

Journal of Experimental and Clinical Medicine

Volumn 4, Issue 2, 2012, Pages 88-91

  Allgulander, Christer ^a,b  

^a KAROLINSKA INSTITUTE   (Sweden)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Comorbidity; Cost of illness; Generalized anxiety disorder (GAD)

Indexed keywords

BEHAVIOR THERAPY; CARDIOVASCULAR DISEASE; CEREBROVASCULAR DISEASE; COGNITIVE DEFECT; COMORBIDITY; DIABETES MELLITUS; DISEASE COURSE; FAMILY; GENERALIZED ANXIETY DISORDER; HEALTH SERVICE; HUMAN; IRRITABILITY; LEISURE; LUNG DISEASE; MYALGIA; NEUROLOGIC DISEASE; PREVALENCE; PRIORITY JOURNAL; PSYCHIATRIC DIAGNOSIS; REVIEW; SLEEP DISORDER; WORK CAPACITY;

EID: 84859602885     PISSN: 18783317     EISSN: 18783325     Source Type: Journal    
DOI: 10.1016/j.jecm.2012.01.006     Document Type: Review

References (48)

1. Nitschke J.B., Sarinopoulos I., Oathes D.J., Johnstone T., Whalen P.J., Davidson R.J., Kalin N.H. Anticipatory activation in the amygdala and anterior cingulate in generalized anxiety disorder and prediction of treatment response. Am J Psychiatry 2009, 166:302-310.
2. Etkin A., Prater K.E., Hoeft F., Menon V., Schatzberg A.F. Failure of anterior cingulate activation and connectivity with the amygdala during implicit regulation of emotional processing in generalized anxiety disorder. Am J Psychiatry 2010, 167:545-554.
3. Brambilla P., Como G., Isola M., Taboga F., Zuliani R., Goljevscek S., Ragogna M., et al. White-matter abnormalities in the right posterior hemisphere in generalized anxiety disorder: a diffusion imaging study. Psychol Med 2011, 42:427-434.
4. Roth W.T., Doberenz S., Dietel A., Conrad A., Mueller A., Wollburg E., Meuret A.E., et al. Sympathetic activation in broadly defined generalized anxiety disorder. J Psychiatry Res 2008, 42:205-212.
5. 2 challenge in generalized anxiety disorder. J Psychopharmacol 2011, 25:43-51.
6. 2 in healthy volunteers as a human experimental medicine: a model of generalized anxiety disorder (GAD). J Psychopharmacol 2011, 25:1192-1198.
7. Borkovec T.D., Roemer L. Perceived functions of worry among generalized anxiety disorder subjects: distraction from more emotionally distressing topics?. J Behav Therap Exp Psychiatry 1995, 26:25-30.
8. Ladouceur R., Gosselin P., Dugas M.J. Experimental manipulation of intolerance of uncertainty: a study of a theoretical model of worry. Behav Res Ther 2000, 38:933-941.
9. MacLeod C., Rutherford E. Information-processing approaches. Assessing the selective, functioning of attention, interpretation, and retrieval. Generalized anxiety disorder: advances in research and practice 2004, 109-142. Guilford Press, New York. R.G. Heimberg, C.L. Turk, D.S. Mennin (Eds.).
10. Generalized anxiety disorder: advances in research and practice 2004, Guilford Press, New York. R.G. Heimberg, C.L. Turk, D.S. Mennin (Eds.).
11. Hale W.W., Klimstra T.A., Meeus W.H.J. Is the generalized anxiety disorder symptom of worry just another form of neuroticism? A 5-year longitudinal study of adolescents from the general population. J Clin Psychiatry 2010, 71:942-948.
12. Mackintosh M.A., Gatz M., Wetherell J.L., Pedersen N.L. A twin study of lifetime generalized anxiety disorder (GAD) in older adults: genetic and environmental influences shared by neuroticism and GAD. Twin Res Hum Genet 2006, 9:30-37.
13. Bebbington P.E., Brugha T.S., Meltzer H., Jenkins R., Ceresa C., Farrell M., Lewis G. Neurotic disorders and the receipt of psychiatric treatment. Psychol Med 2000, 30:1369-1376.
14. Lee S., Ma Y.L., Tsang A., Kwok K. Generalized anxiety disorder with and without excessive worry in Hong Kong. Depr Anx 2009, 26:956-961.
15. Moffitt T.E., Harrington H., Caspi A., Kim-Cohen J., Goldberg D., Gregory A.M., Poulton R. Depression and generalized anxiety disorder: cumulative and sequential comorbidity in a birth cohort followed prospectively to age 32 years. Arch Gen Psychiatry 2007, 64:651-660.
16. Weiller E., Bisserbe J.C., Maier W., Lecrubier Y. Prevalence and recognition of anxiety syndromes in five European primary care settings. A report from the WHO study on psychological problems in general health care. Br J Psychiatry Suppl 1998, 34:18-23.
17. Munk-Jörgensen P., Allgulander C., Dahl A.A., Foldager L., Holm Rasmussen I., Virta A., et al. Prevalence of generalized anxiety disorder in general practice in Denmark, Finland, Norway, and Sweden. Psychiatric Services 2006, 57:1738-1744.
18. Hinton D.E., Park L., Hsia C., Hofmann S., Pollack M.H. Anxiety disorder presentations in Asian populations: a review. CNS Neurosci Ther 2009, 15:295-303.
19. Marques L., Robinaugh D.J., LeBlanc N.J., Hinton D. Cross-cultural variations in the prevalence and presentation of anxiety disorders. Expert Rev Neurother 2011, 11:313-322.
20. Chen P.-Y., Wang S.-C., Poland R.E., Lin K.-M. Biological variations in depression and anxiety between east and west. CNS Neurosci Ther 2009, 15:283-294.
21. Allgulander C. Morbid anxiety as a risk factor in patients with somatic diseases: a review of recent findings. Mind Brain J Psychiatry 2010, 1:11-19.
22. Shiba M., Bower J.H., Maraganore D.M., McDonnell S.K., Peterson B.J., Ahlskog J.E., Schaid D.J., et al. Anxiety disorders and depressive disorders preceding Parkinson's disease: a case-control study. Movem Disord 2000, 15:669-677.
23. Johnson E.K., Jones J.E., Sidenberg M., Hermann B.P. The relative impact of anxiety, depression, and clinical seizure features on health-related quality of life, in epilepsy. Epilepsia 2004, 45:544-550.
24. Martens E.J., de Jonge P., Na B., Cohen B.E., Lett H., Whooley M.A. Scared to death? Generalized anxiety disorder and cardiovascular events in patients with stable coronary heart disease. Arch Gen Psychiatry 2010, 67:750-758.
25. Huang K.L., Su T.P., Chen T.J., Chou Y.H., Bai Y.M. Comorbidity of cardiovascular diseases with mood and anxiety disorder: a population based 4-year study. Psychiatry Clin Neurosci 2009, 63:401-409.
26. Chen Y.-H., Tsai S.-Y., Lee H.-C., Lin H.-C. Increased risk of acute myocardial infarction for patients with panic disorder: a nationwide population study. Psychosom Med 2009, 71:798-804.
27. Engum A. The role of depression and anxiety in onset of diabetes in a large population-based study. J Psychosom Res 2007, 62:31-38.
28. Elman I., Zubieta J.-K., Borsook D. The missing P in psychiatric training. Arch Gen Psychiatry 2011, 68:12-20.
29. Beesdo K., Hoyer J., Jacobi F., Low N.C., Höfler M., Wittche H.U. Association between generalized anxiety levels and pain in a community sample: evidence for diagnostic specificity. J Anx Disord 2009, 23:684-693.
30. Romera I., Férnandez-Pérez S., Montego á.L., Caballero F., Caballero L., Arbesú J.Á., Delgado-Cohen H., et al. Generalized anxiety disorder, with or without co-morbid major depressive disorder, in primary care: prevalence of painful somatic symptoms, functioning and health status. J Affect Disord 2010, 127:160-168.
31. Raphale K.G., Janal M.N., Nayak S., Schwartz J.E., Gallagher M. Psychiatric comorbidities in a community sample of women with fibromyalgia. Pain 2006, 124:117-125.
32. Monti J.M., Monti D. Sleep disturbance in generalized anxiety disorder and its treatment. Sleep Med Rev 2000, 4:263-276.
33. Sandelin R, Ahnemark E, Kowalski J, Allgulander C. Treatment patterns and costs in patients with generalized anxiety disorder (GAD): one-year retrospective analysis of data from national registers in Sweden. Presented at the 30th Annual Conference, ADAA, Baltimore, March 4-7, 2010.
34. Marcks B.A., Weisberg R.B., Edelen M.O., Keller M.B. The relationship between sleep disturbance and the course of anxiety disorders in primary care patients. Psychiatr Res 2010, 178:487-492.
35. Pollack M., Kinrys G., Krystal A., McCall W.V., Roth T., Schaefer K., Rubens R., et al. Eszopiclone coadministered with escitalopram in patients with insomnia and comorbid generalized anxiety disorder. Arch Gen Psychiatry 2008, 65:551-562.
36. Andlin-Sobocki P., Wittchen H.U. Cost of anxiety disorders in Europe. Eur J Neurol 2005, 12:39-44.
37. Revicki DA, Travers K, Wyrwich KW, Svedsäter H, Locklear J, Mattera MS, Sheehan DV, et al. Humanistic and economic burden of generalized anxiety disorder in North America and Europe. J Affect Disord 2011; Dec 8, on line.
38. Bandelow B., Zohar J., Hollander E., Kasper S., Möller H.J. WFSBP task force on treatment guidelines for anxiety obsessive-compulsive post-traumatic stress disorders. World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the pharmacological treatment of anxiety, obsessive-compulsive and post-traumatic stress disorders - first revision. World J Biol Psychiatry 2008, 9:248-312.
39. Hoyer J., Gloster A.T. Psychotherapy for generalized anxiety disorder: don't worry, it works!. Psychiatr Clin No Am 2009, 32:629-640.
40. Leichsenring F., Salzer S., Jaeger U., Kachele H., Kreische R., Leweke F., Rüger U., et al. Short-term psychodynamic psychotherapy and cognitive-behavioral therapy in generalized anxiety disorder: a randomized, controlled trial. Am J Psychiatry 2009, 166:875-881.
41. Robinson E., Titov N., Andrews G., McIntyre K., Schwencke G., Solley K. Internet treatment for generalized anxiety disorder: a randomized controlled trial comparing clinician vs. technician assistance. PLoS One 2010, 5:e10942.
42. Crits-Christoph P., Newman M.G., Rickels K., Gallop R., Connolly Gibbons M.B., Hamilton J.L., Ring-Kurtz S., et al. Combined medication and cognitive therapy for generalized anxiety disorder. J Anx Disord 2011, 25:1087-1094.
43. Ross L.E., McLean L.M. Anxiety disorders during pregnancy and the postpartum period: a systematic review. J Clin Psychiatry 2006, 67:1285-1298.
44. Stein D.J., Bandelow B., Merideth C., Olausson B., Szamosi J., Eriksson H. Efficacy and tolerability of extended release quetiapine fumarate (quetiapine XR) monotherapy in patients with generalised anxiety disorder: an analysis of pooled data from three 8-week placebo-controlled studies. Hum Psychopharmacol Clin Exp 2011, 26:616-628.
45. Pollack M.H. Refractory generalized anxiety disorder. J Clin Psychiatry 2009, 70:32-38.
46. Baldwin DS; Allgulander C, Bandelow B, Ferre F, Pallanti S. An international survey of reported prescribing practice in the treatment of patients with generalised anxiety disorder. World J Biol Psychiatry 2011; Nov 7, on line.
47. Porensky E.K., Dew M.A., Karp J.F., Skidmore E., Rollman B.L., Shear M.K., Lenze E.J. The burden of late-life generalized anxiety disorder: effects on disability, health-related quality of life, and healthcare utilization. Am J Geriatr Psychiatry 2009, 17:473-482.
48. Smoller J.W., Block S.R., Young M.M. Genetics of anxiety disorders: the complex road from DSM to DNA. Depr Anx 2009, 26:965-975.